Clinical Trial Update: Weight-Based Torsemide Dosing in Subjects With Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining weight-based dosing of torsemide in heart failure patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Torsemide (torsemide)

Snippet

Sponsor: New York City Health and Hospitals Corporation | Conditions: Heart Failure | Phase 4 | Status: COMPLETED